Jacques Biton
Keine laufenden Positionen mehr
Profil
Jacques Biton is the founder of Deinove SA. Prior to founding Deinove SA, he worked as a Director at Oroxcell SAS, and as a Principal at Aventis, Inc. and Koninklijke Gist Brocades NV.
Biton received his undergraduate and doctorate degrees from Université de Technologie de Compiègne.
Ehemalige bekannte Positionen von Jacques Biton
| Unternehmen | Position | Ende |
|---|---|---|
| DEINOVE | Gründer | 23.09.2011 |
| Aventis, Inc. | Corporate Officer/Principal | - |
Koninklijke Gist Brocades NV
 Koninklijke Gist Brocades NV Pharmaceuticals: OtherHealth Technology Part of DSM-Firmenich AG, Koninklijke Gist Brocades NV is a Dutch company that manufactures and markets biotechnological products. The private company is based in Delft, the Netherlands. | Corporate Officer/Principal | - |
Oroxcell SAS
 Oroxcell SAS Medical SpecialtiesHealth Technology Oroxcell SAS develops and commercializes in-vtro technologies. The company focuses on bioavailability of compounds issued from life sciences. The firm specializes in both innovative formulations to improve oral absorption, and new in vitro technologies to evaluate ADME parameters, pharmacokinetics and biopharmaceutical discovery. Oroxcell offers access to improved bioavailability, a vital unmet need for many players in markets across the life sciences (pharmacy, cosmetics, veterinary and agro-food sciences). The company was founded in 2004 and is headquartered in Romainville, France. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jacques Biton
| Université de Technologie de Compiègne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Oroxcell SAS
Oroxcell SAS Medical SpecialtiesHealth Technology Oroxcell SAS develops and commercializes in-vtro technologies. The company focuses on bioavailability of compounds issued from life sciences. The firm specializes in both innovative formulations to improve oral absorption, and new in vitro technologies to evaluate ADME parameters, pharmacokinetics and biopharmaceutical discovery. Oroxcell offers access to improved bioavailability, a vital unmet need for many players in markets across the life sciences (pharmacy, cosmetics, veterinary and agro-food sciences). The company was founded in 2004 and is headquartered in Romainville, France. | Health Technology |
Koninklijke Gist Brocades NV
Koninklijke Gist Brocades NV Pharmaceuticals: OtherHealth Technology Part of DSM-Firmenich AG, Koninklijke Gist Brocades NV is a Dutch company that manufactures and markets biotechnological products. The private company is based in Delft, the Netherlands. | Health Technology |
Deinove SA
 Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
| Aventis, Inc. |